MedPath

The Efficacy of Stinging Nettle (Urtica Dioica) in Patients with Benign Prostatic Hyperplasia: A Randomized Double-Blind Study in 100 Patients

Phase 2
Conditions
Benign Prostatic Hyperplasia.
????? ??? ??? ??? ???????
N 40.0
Registration Number
IRCT201107295069N4
Lead Sponsor
Gachsaran Islamic Azad University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Male
Target Recruitment
100
Inclusion Criteria

known case of Benign Prostatic Hyperplasia, between 40 and 80 years old. Exclusion criteria: the presence of urinary and kidney diseases.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Stinging Nettle Medicine. Timepoint: before intervention and every week for eight weeks. Method of measurement: Prostate Symptom Severity Measuring Scale.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath